TITLE
Sunitinib effect on renal cancer xenograft tumors

SUMMARY
Analysis of Kyoto University Renal Cancer (KURC) xenograft tumor models, KURC1, KURC2, KURC3, treated with sunitinib, a small molecule inhibitor of receptor tyrosine kinases that is used to treat RC. Results provide insight into molecular mechanisms underlying acquired sunitinib resistance in RC.

ORGANISM
Homo sapiens

PLATFORM
GPL6244 : [HuGene-1_0-st] Affymetrix Human Gene 1.0 ST Array [transcript (gene) version]

CITATIONS
Shibasaki N, Yamasaki T, Kanno T, Arakaki R et al. Role of IL13RA2 in Sunitinib Resistance in Clear Cell Renal Cell Carcinoma. PLoS One 2015;10(6):e0130980. PMID:Â  26114873

